Publications by authors named "Alexander Marme"

Claim this Profile
E
Extracellular Vesicles Derived From the Feces of Pregnant Women Modulate T Cells Toward a Pregnancy-Supportive Phenotype In Vitro.
Stefanie Dietz-Ziegler, Samantha Kewitz, Gabriele Kaiser, Jessica Rühle, Alexander Marmé

Eur J Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Leucocyte Antigen G and Murine Qa-2 Are Critical for Myeloid Derived Suppressor Cell Expansion and Activation and for Successful Pregnancy Outcome.
Stefanie Dietz, Julian Schwarz, Ana Velic, Irene González-Menéndez, Leticia Quintanilla-Martinez

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles released by myeloid-derived suppressor cells from pregnant women modulate adaptive immune responses.
Stefanie Dietz, Julian Schwarz, Jessica Rühle, Martin Schaller, Birgit Fehrenbacher

Cell Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocytic Myeloid-Derived Suppressor Cells (GR-MDSC) in Breast Milk (BM); GR-MDSC Accumulate in Human BM and Modulate T-Cell and Monocyte Function.
Natascha Köstlin, Carolin Schoetensack, Julian Schwarz, Bärbel Spring, Alexander Marmé

Front Immunol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4.
Natascha Köstlin, Anna-Lena Ostermeir, Bärbel Spring, Julian Schwarz, Alexander Marmé

Eur J Immunol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses.
Natascha Köstlin, Hellen Kugel, Bärbel Spring, Anja Leiber, Alexander Marmé

Eur J Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Screening for mental stress and the wish for psychological support in patients with breast cancer].
Norbert Schäffeler, Paul Enck, Ines Riessen, Diana Seitz, Alexander Marmé

Z Psychosom Med Psychother· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas.
Alexander Marmé, Hans-Peter Zimmermann, Gerhard Moldenhauer, Marina Schorpp-Kistner, Claudia Müller

Int J Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures.
Sonja Muffler, Hans-Jürgen Stark, Mara Amoros, Berit Falkowska-Hansen, Karsten Boehnke

Stem Cells· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.
Chengwen Zhang, Till Wenger, Jürgen Mattern, Septimia Ilea, Christian Frey

Cancer Biol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.
Alexander Stoeck, Sabine Schlich, Yasmin Issa, Verena Gschwend, Till Wenger

Cancer Lett· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.
Philipp Kiewe, Stephan Hasmüller, Steffen Kahlert, Maja Heinrigs, Brigitte Rack

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers.
Brigitte Gückel, Christine Rentzsch, Maria-Dorothea Nastke, Alexander Marmé, Ines Gruber

J Cancer Res Clin Oncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.
Chengwen Zhang, Alexander Marmé, Till Wenger, Paul Gutwein, Lutz Edler

Int J Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoids and progression of breast cancer.
Ingrid Herr, Alexander Marme

Cancer Biol Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preeclampsia: increased expression of soluble ADAM 12.
Sabine Gack, Alexander Marmé, Frederik Marmé, Gunnar Wrobel, Birgitta Vonderstrass

J Mol Med (Berl)· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells.
Paul Gutwein, Alexander Stoeck, Svenja Riedle, Daniela Gast, Steffen Runz

Clin Cancer Res· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD80-transfected human breast cancer cell variant induces HER-2/neu-specific T cells in HLA-A*02-matched situations in vitro as well as in vivo.
Brigitte Gückel, Susanne Stumm, Christine Rentzsch, Alexander Marmé, Geeske Mannhardt

Cancer Immunol Immunother· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAMxCD64 (HEA125x197) bispecific antibody.
Christof Schweizer, Gudrun Strauss, Matthias Lindner, Alexander Marmé, Yashwant M Deo

Cancer Immunol Immunother· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal bispecific antibody (HEA125xOKT3) therapy inhibits malignant ascites production in advanced ovarian carcinoma.
Alexander Marmé, Gudrun Strauss, Gunther Bastert, Eva-Maria Grischke, Gerhard Moldenhauer

Int J Cancer· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis